According to Cognitive Market Research, The Global Canine Arthritis Treatment market will be USD 2685.2 million in 2023 and expand at a compound annual growth rate (CAGR) of 4.50% from 2023 to 2030.
North America Canine Arthritis Treatment is the major market with more than 40% of the global revenue with a market size of USD 1074.08 million in 2023 and will grow at a compound annual growth rate (CAGR) of 2.7% from 2023 to 2030.
Europe Canine Arthritis Treatment accounted for a share of over 30% of the global market size of USD 805.56 million in 2023.
Asia Pacific Canine Arthritis Treatment held the market of more than 23% of the global revenue with a market size of USD 617.60 million in 2023 and will grow at a compound annual growth rate (CAGR) of 6.5% from 2023 to 2030.
South America's Canine Arthritis Treatment market has more than 5% of the global revenue with a market size of USD 134.26 million in 2023 and will grow at a compound annual growth rate (CAGR) of 3.9% from 2023 to 2030.
Middle East and Africa Canine Arthritis Treatment are the major markets of more than 2% of the global revenue with a market size of USD 53.70 million in 2023 and will grow at a compound annual growth rate (CAGR) of 4.2% from 2023 to 2030.
The increase in arthritis among the animals drives the companion animal arthritis in the Canine Arthritis Treatment market.
Demand for companion animal care in the Canine Arthritis Treatment market.
The surgery and NSAIDs category held the highest Canine Arthritis Treatment market revenue share in 2023.
